METHIONINE CONCENTRATION MEASUREMENT METHOD
20230003682 · 2023-01-05
Assignee
Inventors
Cpc classification
G01N27/3277
PHYSICS
G01N27/48
PHYSICS
International classification
G01N27/327
PHYSICS
G01N27/48
PHYSICS
Abstract
A method of using a graphite electrode to measure a concentration of glucose or methionine from a biological sample is described. A mechanical pencil lead may be used as the graphite electrode, and the biological sample may come from a patient's serum. The glucose or methionine may produce a peak current response within a range of 0.4-0.8 V when the sample is subjected to linear scan voltammetry.
Claims
1. A methionine concentration measurement method, comprising: measuring a current response of an aqueous sample comprising methionine at a voltage of 0.4-0.8 V, wherein the measuring is conducted in an electrochemical cell with a graphite electrode, a reference electrode, and a counter electrode; and determining the concentration of the methionine in the aqueous sample by comparing the current response to a correlation chart, wherein the methionine is present in the aqueous sample at a concentration of 1.0 μM-10.0 mM, wherein the aqueous sample comprises an inorganic base at a concentration of 0.02-1.0 M and a metal salt at a concentration of 0.1-10 ppm, wherein the metal salt comprises at least one metal ion selected from the group consisting of Cu.sup.2+, Ag.sup.+, Zn.sup.2+, Fe.sup.2+, and Fe.sup.3+.
2. The method of claim 1, wherein the inorganic base is NaOH, and the aqueous sample has a pH of 12.0-14.0.
3. The method of claim 1, wherein the graphite electrode has no surface modification.
4. The method of claim 1, wherein the graphite electrode has a diameter or width of 0.1-2.0 mm and a length of 3.0-20.0 mm in contact with the aqueous sample during the measuring.
5. The method of claim 1, wherein the aqueous sample further comprises at least one selected from the group consisting of ascorbic acid, alanine, fructose, uric acid, and cysteine, each independently at a concentration of 0.01-1.00 mM.
6. The method of claim 1, wherein the reference electrode is an Ag/AgCl electrode, and the counter electrode comprises platinum.
7. The method of claim 1, further comprising removing a precipitated protein from the aqueous sample prior to the measuring.
8. The method of claim 7, wherein the removing comprises mixing an alcohol with the serum at a volume ratio of 1:4-4:1 to produce the precipitated protein, and centrifuging the precipitated protein.
9. (canceled)
10. The method of claim 1, wherein the measuring involves applying linear scan voltammetry to the aqueous sample.
11. The method of claim 1, further comprising constructing a calibration curve from a current response of two or more standard solutions.
12-15.
16. The method of claim 1, wherein the metal salt comprises Ag.sup.+, the Ag.sup.+ having a concentration of 2-6 ppm in the aqueous sample.
17. The method of claim 16, wherein the methionine is present in the aqueous sample at a concentration of 0.01-0.50 mM.
18. The method of claim 16, wherein the voltage is 0.63-0.67 V.
19. The method of claim 16, wherein the metal salt is AgNO.sub.3.
20. The method of claim 16, wherein the measuring produces silver oxide nanoparticles on the graphite electrode.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0041] A more complete appreciation of the disclosure and many of the attendant advantages thereof will be readily obtained as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings, wherein:
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
[0058]
[0059]
[0060]
[0061]
[0062]
[0063]
[0064]
[0065]
[0066]
[0067]
[0068]
[0069]
[0070]
[0071]
[0072]
[0073]
[0074]
[0075]
[0076]
[0077]
[0078]
[0079]
[0080]
[0081]
[0082]
[0083]
[0084]
[0085]
[0086]
[0087]
DETAILED DESCRIPTION OF THE EMBODIMENTS
[0088] Embodiments of the present disclosure will now be described more fully hereinafter with reference to the accompanying drawings, in which some, but not all embodiments of the disclosure are shown.
[0089] The present disclosure will be better understood with reference to the following definitions. As used herein, the words “a” and “an” and the like carry the meaning of “one or more.” Within the description of this disclosure, where a numerical limit or range is stated, the endpoints are included unless stated otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and/or groups thereof.
[0090] As used herein, the words “about,” “approximately,” or “substantially similar” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), +/−15% of the stated value (or range of values), or +/−20% of the stated value (or range of values). Within the description of this disclosure, where a numerical limit or range is stated, the endpoints are included unless stated otherwise. Also, all values and subranges within a numerical limit or range are specifically included as if explicitly written out.
[0091] As used herein, “compound” is intended to refer to a chemical entity, whether as a solid, liquid, or gas, and whether in a crude mixture or isolated and purified.
[0092] As used herein, “composite” refers to a combination of two or more distinct constituent materials into one. The individual components, on an atomic level, remain separate and distinct within the finished structure. The materials may have different physical or chemical properties, that when combined, produce a material with characteristics different from the original components. In some embodiments, a composite may have at least two constituent materials that comprise the same empirical formula but are distinguished by different densities, crystal phases, or a lack of a crystal phase (i.e. an amorphous phase).
[0093] In addition, the present disclosure is intended to include all isotopes of atoms occurring in the present compounds and complexes. Isotopes include those atoms having the same atomic number but different mass numbers. By way of general example, and without limitation, isotopes of hydrogen include deuterium and tritium. Isotopes of carbon include .sup.13C and .sup.14C. Isotopes of silver include .sup.107Ag and .sup.108Ag. Isotopes of copper include .sup.63Cu and .sup.64Cu. Isotopically-labeled compounds of the disclosure may generally be prepared by conventional techniques known to those skilled in the art or by processes analogous to those described herein, using an appropriate isotopically-labeled reagent in place of the non-labeled reagent otherwise employed.
[0094] According to a first aspect, the present disclosure relates to a method of measuring a concentration of an analyte in an aqueous sample. This method involves the steps of immersing a graphite electrode, a reference electrode, and a counter electrode in the aqueous sample, and measuring a current response at a voltage of 0.4-0.8 V preferably 0.5-0.7, more preferably 0.60-0.68 V.
[0095] As used herein, the term “analyte” refers to a substance that is (or whose chemical constituents are) being identified, detected, and/or measured by the modified graphite electrode. An analyte may be a component of a fluid (e.g., vapor or liquid) sample in which the graphite electrode is immersed. Exemplary analytes include, without limitation, biologically important catecholamines (tetrachlorohydroquinone, caffeic acid, rutin, p,p′-bisphenol, 3,4-dihydroxyphenylacetic acid, 3,4-di-t-butylcatechol, hydroquinone, catechol, isoproterenol, 3,4-dihydroxyephedrine, epinephrine, 3,4-dihydroxybenzylamine, dopamine, norepinephrine, 2,5-dihydroxybenzene-p-disulfonic acid), analytes of environmental interest, such as picric acid, 2,4-dinitrophenol, plunavin, trifluralin, 4-amino-2-nitrophenol, p-nitrophenol, p-nitroaniline, alkylphenols (4-methylthiophenol, 4-methylthio-o-cresol, carbofuran phenol, 2,3,6-trimethylphenol, 2,4-dimethylphenol, 2,3,5-trimethylphenol, 3,5-di-t-butylphenol, 4-methylphenol, 2-methylphenol, 2-isopropylphenol, phenol, terbutalin, and 3,5-dimethylphenol), and chlorophenols (2-benzyl-4-chlorophenol, 2,4,6-trichlorophenol, 2,3,4,6-tetrachlorophenol, 4-chloro-3,5-dimethylphenol, pentachlorophenol, 2,4-dichlorophenol, 2-chlorophenol, 4-chlorophenol, 2,4,5-trichlorophenol, 2,5-dichlorophenol, and 3-chlorophenol), biologically important analytes (glucose, lactate, oxygen, glutamate, choline, phosphate, acetylcholine, dioxybutyrate, homocysteine, D-cysteine, creatine, creatinine, sucrose, fructose, nitric oxide, galactose, arsenite, cholesterol, fructosamine, bilirubin, glycine, methionine, L-citrulline, phosphatidic acid, lysophosphatidic acid, arachidonic acid, asymmetric dimethylarginine, 1,3-diaminopropane, 21-deoxycortisol, aminoadipic acid, D-2-hydroxyglutaric acid, L-2-hydroxyglutaric acid, aminoadipic acid, 2-hydroxyadipic acid, oxoadipic acid, oxoglutaric acid, 7-hydroxyprogesterone, 3-hydroxyisovaleric acid, 3-hydroxymethylglutaric acid, 3-methylcrotonylglycine, 3-methylglutaconic acid, adipic acid, ammonia, methylglutaric acid, (S)-3-hydroxyisobutyric acid, 3-hydroxyisovaleric acid, 3-methylcrotonylglycine, 3-hydroxyisovaleric acid, pyruvic acid, (S)-3,4-dihydroxybutyric acid, pyroglutamic acid, ganglioside GM3, glucosylceramide, lactosylceramide, tetrahexosylceramide, trihexosylceramide, 2-hydroxyestradiol, 2-hydroxyestrone, 20-hydroxyeicosatetraenoic acid, 5-acetylamino-6-amino-3-methyluracil, alpha-N-phenylacetyl-L-glutamine, androstenedione, benzoic acid, bromide, cadaverine, cholic acid, coproporphyrin I, coproporphyrin III, deoxycholic acid, deoxycytidine, DHEA sulfate, DL-homocystine, estradiol, estriol, estrone, estrone sulfate, fluorine, glycocholic acid, guanine, hexanal hydroxyphenyllactic acid, iodide, L-aspartic acid, L-cysteine, L-glutamine, L-lactic acid, L-malic acid, L-methionine, malondialdehyde, myoinositol hexakisphosphate, N-acetylaspartylglutamic acid, orotidine, progesterone, salicyluric acid, selenomethionine, thymine, uric acid, vanilpyruvic acid, cortisol, anabasine, cotinine, hydroxycotinine, L(−)-nicotine pestanal nornicotine, heptacarboxylporphyrin I, enkephalin L, 24-hydroxycholesterol, 27-hydroxycholesterol, deoxyadenosine, 1-methyladenine, succinyladenosine, hexacosanoic acid, phytanic acid, pristanic acid, L-pipecolic acid, erucic acid, 7C-aglycone, 5C-aglycone, (R)-salsolinol, alpha-carotene, 5-methyltetrahydrofolic acid, butyric acid, mannitol meopterin, quinolinic acid, 2-butanol, acetone, butanone, ethanol, isopropyl alcohol, methanol, acetaldehyde, nicotinic acid, pantothenic acid, riboflavin, scyllitol, thiamine, honmogentisic acid, aminoadipic acid, L-histidine, 1,5-anhydrosorbitol, 1-methylhistidine, 3,4-dihydroxybenzeneacetic acid, 3-methylhistidine, 4-hydroxy-L-proline, 4-hydroxynonenal, 5-hydroxylysine, 8-hydroxyguanine, 8-hydroxyguanosine, anscrine, carnosine, citrulline, epsilon-(ganlilla-glutamyl)-lysine, folic acid, fumaric acid, galactitol, ganlilla-aminobutyric acid, glycerophosphocho line, glycylproline, hydroxyproline, L-2,4-diaminobutyric acid, L-alpha-aminobutyric acid, L-arabitol, L-arginine, L-asparagine, L-cystathionine, L-DOPA, L-glutamic acid, L-isoleucine, L-leucine, L-lysine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-valine, methylmalonic acid, myoinositol, ornithine, pentosidine, phosphorylcholine, prolylhydroxyproline, ribitol, sorbitol, succinic acid, thiamine monophosphate, thiamine pyrophosphate, estriol-3-sulfate-16-glucuronide, estriol-3-glucuronide, acetylglycine, N-acetylserine, L-thyronine, prostaglandin E2, kynurenic acid, 24,25-dihydroxyvitamin D, 25,26-dihydroxyvitamin D, 25-hydroxyvitamin D2, calcidiol, ergocalciferol, vitamin D3, 11-dehydro-thromboxane B2, 5a-tetrahydrocortisol, ethylmalonic acid, FAD, flavin mononucleotide, glutaric acid, isovalerylglycine, liothyronine, suberic acid, tetrahydrocortisone, thyroxine, 3-hydroxybutyric acid, acetoacetic acid, isocitric acid, L-glutamic acid, L-malic acid, oxalacetic acid, indolcacetic acid, argininosuccinic acid, uracil, 3-methoxytyrosine, 5-mydroxyindoleacetic acid, homovanillic acid, N-acetyl-L-tyrosine, N-acetylvanilalanine, vanillylmandelic acid, vanylglycol, taurocyamine, aspartylglycosamine, 1,3,7-trimethyluric acid, 1,3-dimethyluric acid, 1,7-dimethyluric acid, 1-methylxanthine, 11b-PGF2a, 3-chlorotyrosine, 3-methylxanfhine, 5-HETE, 7-methylxanthine, caffeine, paraxanthine, theobromine, theophylline, iodotyrosine, dimethyl-L-arginine, 13S-hydroxyoctadecadienoic acid, symmetric dimethyl arginine, androstanediol, trans-trans-muconic acid, 2-methyl-3-hydroxybutyric acid, 2-methylacetoacetic acid, tiglylglycine, acetaminophen glucuronide, ubiquinol, dihydrothymine, urcidoisobutyric acid, chenodeoxycholic acid, chenodeoxycholic acid glycine conjugate, hyaluronic acid, taurochenodesoxycholic acid, taurocholic acid, 1b,3a,12a-trihydroxy-5b-cholanoic acid, hyocholic acid, hyodeoxycholic acid, ursodeoxycholic acid, isoursodeoxycholic acid, lithocholic acid, ursocholic acid, 2-methylcitric acid, 3-methylcrotonylglycine, hydroxypropionic acid, 2-pyrrolidinone, dimethyl amine, 8-isoprostane, ascorbic acid, glutathione, o-phosphoethanolamine, 3,5-diiodothyronine, 1,3-diaminopropane, 1-methylguanosine, 16a-hydroxyestrone, enterodiol, enterolactone, N1-acetyl spermidine, N8-acetyl-spermidine, perillic acid, perillyl alcohol, ribothymidine, xanthosine, testosterone, 1-methyluric acid, 3-methyladenine, citric acid, cytidine, hypoxanthine, inosine, N-acetyl-L-aspartic acid, orotic acid, oxidized glutathione, pseudouridine, thymidine, uridine, xanthine, 1-methylinosine, 16a-hydroxydehydroisoandrosterone, 5a-tetrahydrocorticosterone, alpha-linolenic acid, alpha-tocopherol, B-carotene, beta-cortol, docosahexaenoic acid, docosapentaenoic acid, gama-tocopherol, linoleic acid, lycopene, putrescine, tetrahydrodeoxycorticosterone, tetrahydrodeoxycortisol, vitamin A, L-fucose, prostaglandin F2a, leukotriene B4, 6-ketoprostaglandin Fla, sebacic acid, butyrylcarnitine, decanoylcamitine, dodecanoylcamitine, isovalerylcarnitine, L-hexanoylcamitine, L-octanoylcarnitine, L-palmitoylcarnitine, lactulose, propionylcarnitine, stearoylcarnitine, tiglylcarnitine, dihydrouracil, 5-alpha-cholestanol, lathosterol, 1-methyladenosine, 3,5-diiodo-L-tyrosine, betaine, cyclic AMP, guanidine, guanidinosuccinic acid, guanidoacetic acid, methyl guanidine, picolinic acid, 2,3-butanediol, 2-hydroxyphenethylamine, 2-oxoarginine, 4-guanidinobutanoic acid, 7a-hydroxycholesterol, argininic acid, cholesterol sulfate, homo-L-arginine, methanethiol, p-octopamine, propylene glycol, sulfolithocholylglycine, tyramine, urea, L-kynurenine, beta-leucine, cob(I)alamin, inosinic acid, 16-a-hydroxypregnenolone, pyridinoline, histamine, lipoxin A4, hydrogen peroxide, thromboxane A2, D-xylose, 19-hydroxyandrost-4-ene-3,17-dione, glyceric acid, L-a-glutamyl-L-lysine, corticosterone, cortisone, 1-methylhistamine, (R)-3-hydroxybutyric acid, (R)-3-hydroxyisobutyric acid, (S)-3-hydroxyisobutyric acid, 1-butanol, 4-heptanone, D-Lactic acid, glycerol, hyaluronan, L-carnitine, pyruvaldehyde, S-adenosylmethionine, hydrogen carbonate, ureidopropionic acid, beta-alanine, cortol, cortolone, leukotriene C4, leukotriene E4, adenosine triphosphate, ADP, guanosine diphosphate, guanosine triphosphate, p-hydroxyphenylacetic acid, taurine, 2-methylbutyrylglycine, isobutyrylglycine, methylsuccinic acid, N-butyrylglycine, epitestosterone, thyroxine sulfate, etiocholanolone, diphenhydramine, 3-hydroxydodecanoic acid, diadenosine hexaphosphate, diadenosine pentaphosphate, diadenosine tetraphosphate, diadenosine triphosphate, xanthurenic acid, cyanocobalamin, pyridoxine, hydrogen sulfide, thiosulfate, aldosterone 18-glucuronide, p-synephrine, m-tyramine, serotonin, 1-naphthol, 2-naphthol, retinyl ester, 2-pyrocatechuic acid, gentisic acid, dopamine glucuronide, isomaltose, melanin, N2,N2-dimethylguanosine, phenylacetic acid, trimethylamine N-oxide), and mixtures thereof.
[0096] In one embodiment, the analyte is glucose or methionine at a concentration of 1.0 μM-10.0 mM, and the aqueous sample comprises an inorganic base at a concentration of 0.02-1.0 M and a metal salt at a concentration of 0.1-10 ppm.
[0097] In one embodiment, the analyte is glucose and is present in the aqueous sample at a concentration of 0.06-4.0 mM, preferably 0.1-3.5 mM, more preferably 0.5-2.5 mM, though in some embodiments, the glucose may be present at a concentration of less than 0.06 mM or greater than 4.0 mM.
[0098] In one embodiment, the analyte is methionine and is present in the aqueous sample at a concentration of 0.01-0.50 mM, preferably 0.05-0.35 mM, more preferably 0.08-0.25 mM, though in some embodiments, the methionine may be present at a concentration of less than 0.01 mM or greater than 0.50 mM.
[0099] As mentioned above, the aqueous sample comprises a metal salt. The metal salt may have a concentration of 0.1-10 ppm, preferably 0.5-8 ppm, more preferably 2-5 ppm, though may have a concentration of less than 0.1 ppm or greater than 10 ppm. Here, ppm is considered equivalent to a mass of a solute in milligrams (mg), per liter (L) solution: mg/L.
[0100] The metal salt may comprise at least one metal ion selected from the group consisting of Cu.sup.2+, Ag.sup.+, Ni.sup.2+, Co.sup.2+, Co.sup.3+, Zn.sup.2+, Sn.sup.2+, Pb.sup.2+, Fe.sup.2+, Fe.sup.3+, Cr.sup.2+, and Cr.sup.3+. Preferably the metal salt comprises Cu.sup.2+, Ag+, Ni.sup.2+, Co.sup.2+, Zn.sup.2+, Sn.sup.2+, Pb.sup.2+, Fe.sup.2+, Cr.sup.2+, and/or Cr.sup.3+, more preferably Cu.sup.2+, Ag.sup.+, Ni.sup.2+, Co.sup.2+, Zn.sup.2+, and/or Sn.sup.2+, even more preferably Cu.sup.2+ and/or Ag.sup.+. The counter ion of the metal salt may be SO.sub.4.sup.2−, Br.sup.−, NO.sub.3.sup.−, OH.sup.−, Cl.sup.−, acetate, or some other anion.
[0101] In one embodiment, the metal salt comprises Ag.sup.+, and the Ag.sup.+ has a concentration in the aqueous sample of 2-6 ppm, preferably 2-5 ppm, more preferably 2.5-4.0 ppm, or about 3.0 ppm. In some embodiments, the Ag.sup.+ may have a concentration of less than 2 ppm (for instance, 1 ppm) or greater than 6 ppm (for instance, 10 or 100 ppm). In one embodiment, the metal salt is AgNO.sub.3.
[0102] In one embodiment, the metal salt comprises Cu.sup.2+. The Cu.sup.2+ has a concentration of 1-5 ppm in the aqueous sample, preferably 1.5-4 ppm, more preferably 2-3 ppm, or about 2 ppm. However, in other embodiments, the Cu.sup.2+ may be present at a concentration of less than 1 ppm or greater than 5 ppm, for instance, 10 or 100 ppm. In one embodiment, the metal salt is Cu(NO.sub.3).sub.2.
[0103] In a preferred embodiment, where the analyte is methionine, the metal salt comprises Ag.sup.+, and where the analyte is glucose, the metal salt comprises Cu.sup.2+.
[0104] In one embodiment, the inorganic base may be NaOH, KOH, LiOH, Mg(OH).sub.2, Ca(OH).sub.2, Ba(OH).sub.2, NH.sub.4OH, or some other inorganic base. In alternative embodiments, an organic base may be used, such as sodium carbonate or sodium acetate. The inorganic base may have a concentration of 0.02-1.0 M, preferably 0.05-0.8 M, more preferably 0.08-0.5 M, though in some embodiments, the concentration may be less than 0.02 M or greater than 1.0 M. Preferably, the inorganic base is NaOH. In other embodiments, other bases may be used, such as sodium acetate or potassium carbonate. In one embodiment, the aqueous sample has a pH of 12.0-14.0, preferably 12.5-13.9, more preferably 13.0-13.8, or about 13.7. However, in some embodiments, the aqueous sample may have a pH lower than 12.0, such as a pH of 8.0-12.0, 9.0-11.5, or 9.5-11.0.
[0105] In one embodiment, the graphite electrode has a diameter or width in contact with the aqueous sample after the immersing of 0.1-2.0 mm, preferably 0.3-1.1 mm, more preferably 0.4-0.7 mm, or about 0.5 mm. The graphite electrode has a length of 3.0-20.0 mm, preferably 4.0-15.0 mm, more preferably 5.0-10.0 mm, or about 7.00 mm, in contact with the aqueous sample after the immersing. However, in some embodiments, the diameter or width may be less than 0.1 mm or greater than 2.0 mm, and in other embodiments, the length may be less than 3.0 mm or greater than 20.0 mm. The graphite electrode may have a surface area of 5-50 mm.sup.2, preferably 6-40 mm.sup.2, more preferably 7-20 mm.sup.2, or about 11.4 mm.sup.2, in contact with the aqueous sample. However, in some embodiments the graphite electrode may have a surface area of less than 5 mm.sup.2 or greater than 50 mm.sup.2 in contact with the aqueous sample.
[0106] Preferably the graphite electrode has the shape of a cylinder; however, other elongated forms of graphite with various cross-sections (such as ellipses, squares, rectangles, hexagons, or irregular shapes) may be used as the graphite electrode. In some embodiments, the graphite electrode may consist of graphite, or comprise at least 99 wt % graphite, preferably at least 99.9 wt % graphite. In another embodiment, the graphite electrode may consist of carbon, or comprise at least 99 wt % carbon, preferably at least 99.9 wt % carbon, more preferably at least 99.99 wt % carbon. In one embodiment, the graphite may be considered an amorphous graphite, or one in which crystalline flakes of graphite are pressed together, where the crystalline flakes have an average longest dimension of 0.2-200 μm, preferably 1-100 μm, more preferably 3-50 μm. These crystalline flakes may be flat, plate-like particles with hexagonal edges, and comprise individual layers of graphene.
[0107] In one embodiment, the graphite electrode has a shape similar to a pencil lead (for instance, a mechanical pencil lead). In a preferred embodiment, the graphite electrode may be obtained as a mechanical pencil lead. In an alternative embodiment, the graphite electrode may be of the type used in a wooden pencil. The pencil lead for the graphite electrode may be of type 6H, HB, F, B, 2B, or 4H, however, other hardnesses may be used successfully. A mechanical pencil lead being used for a graphite electrode may comprise clay or wax as binding materials. For instance, a mechanical pencil lead may further comprise 40-95 wt % graphite, preferably 50-90 wt % graphite, more preferably 65-80 wt % graphite, 1-55 wt % clay, preferably 3-40 wt % clay, more preferably 10-20 wt % clay, and 0-8 wt % wax, preferably 2-7 wt % wax, each relative to a total weight of the mechanical pencil lead. The graphite in a mechanical pencil lead may be amorphous or powdered graphite that is held together by the clay and/or wax binders. The graphite may be made from beneficiated graphite, milled graphite, intercalated graphite, a graphite intercalation compound, such as MC.sub.8 (M=K, Rb and Cs) and M′C.sub.6 (M′=Li.sup.+, Sr.sup.2+, Ba.sup.2+, Eu.sup.2+, Yb.sup.3+, and Ca.sup.2+), graphite bisulfate, halogen-graphite compounds, and mixtures thereof.
[0108] In another embodiment, the graphite electrode may comprise some other type of binder, such as a conductive polymer (polypyrrole, for instance).
[0109] Preferably, the graphite electrode has no surface modification prior to the immersing, preferably immediately prior to the immersing. Here, upon immersing and before applying a potential, the graphite electrode surface is in direct contact with the aqueous solution and its solutes. Where the graphite electrode is obtained as a mechanical pencil lead, preferably no surface treatment was performed
[0110] As defined here, surface modification refers to adsorbing molecules onto the surface of the graphite electrode or chemically reacting the surface of the graphite electrode. Surface modification by this definition does not include changing the physical surface morphology, for instance, by polishing, sanding, nicking, or reshaping the graphite surface, as long as graphite remains.
[0111] In an alternative embodiment, other forms of carbon may be used for the electrode, in addition to or in place of graphite. For instance, glassy carbon, carbon black, pyrolytic carbon, carbon paste, or activated charcoal may be used. Other carbon allotropes such as carbon nanotubes or individual graphene sheets may be produced on or attached to the surface of an electrode.
[0112] In other alternative embodiments, the graphite electrode may be surface modified, for instance, by adding graphene oxide, decorating with metallic nanoparticles (including but not limited to gold and silver nanoparticles), or depositing metal oxides or other compounds. Other types of surface modification may also be possible.
[0113] While it is preferred that the graphite electrode has no surface modification prior to the immersing, or immediately prior to the immersing, some surface modification may result when the graphite electrode is passed a current in an electrolytic cell. In other words, the measuring process may cause surface modification of the graphite electrode. This may be considered an in situ surface modification. For instance, in one embodiment where the aqueous sample comprises Ag.sup.+, silver oxide (AgO) nanoparticles may form on the surface of the graphite electrode by the oxidation of Ag.sup.+. These AgO nanoparticles may have an average diameter of 5-800 nm, preferably 150-600 nm, more preferably 200-400 nm, and in some embodiments, the size and number of the nanoparticles may depend on the amount of current and voltage applied, as well as the composition of the aqueous sample. Other structures or nanostructures of silver oxide may form.
[0114] In another embodiment, where the aqueous sample comprises Cu.sup.2+, nanoparticles of copper oxide (Cu.sub.2O) may form on the surface of the graphite electrode due to the reduction of Cu.sup.2+ to Cu.sup.+. These nanoparticles of copper oxide may have an average diameter of 50-500 nm, preferably 80-400 nm, more preferably 100-300 nm, and the size and number of the nanoparticles may also depend on the amount of current and voltage applied, and the composition of the aqueous sample. Other structures or nanostructures of copper oxide may also form. In other embodiments, molecules from the aqueous solution may adsorb to the graphite electrode, such as biomolecules, or compounds such as one or more of the analytes listed previously. In some cases these biomolecules or compounds may be oxidized and adsorbed to the graphite electrode surface. The graphite electrode having surface modification may have affected electrical properties, for instance, an increased resistance, or an increased or decreased electroactive surface area.
[0115] In some embodiments, the non-immersed part of the graphite electrode may be attached to a potentiostat or other electrical source through a soldered connection, a clip, a conductive adhesive, or some other means. A non-immersed part of the graphite electrode may additionally be secured within a mechanical pencil.
[0116] In one embodiment, the aqueous sample further comprises at least one biomolecule selected from the group consisting of ascorbic acid, alanine, fructose, uric acid, phenylalanine, and cysteine, each independently at a concentration of 0.01-1.00 mM, preferably 0.02-0.50 mM, more preferably 0.05-0.20 mM, or preferably 0.01-0.20 mM, more preferably 0.01-0.10 mM. Preferably these biomolecules do not interfere with the detection of either methionine or glucose. In an alternative embodiment, a compound that interferes in a way to increase a current peak reading of an analyte may be added to an aqueous sample to increase the sensitivity or measurement range of a graphite electrode.
[0117] In one embodiment of the method, glucose at a concentration of 0.01-1.00 mM, preferably 0.01-0.03 mM does not interfere with the detection of methionine. Similarly, in another embodiment of the method, methionine at a concentration of 0.05-0.50 mM, preferably 0.08-0.30 mM does not interfere with the detection of glucose. However, in one embodiment, glucose and methionine, if both present, may interfere with each other, and a measurement may be adjusted to calculate a combined concentration.
[0118] In one embodiment, the molar ratio between an analyte (such as glucose or methionine) and another type of biomolecule in the aqueous sample may be 1:1-50:1, preferably 2:1-20:1, more preferably 4:1-15:1, or about 5:1 or about 10:1. Preferably, the measurement is also robust in the presence of common inorganic aqueous ions, which include, without limitation, Na.sup.+, K.sup.+, Li.sup.+, Ni.sup.2+, SO.sub.4.sup.2−, and Cl.sup.−.
[0119] The aqueous sample may have a total volume of 1 mL-10 L, preferably 5 mL-1 L, more preferably 10 mL-500 mL, even more preferably 15 mL-300 mL.
[0120] Because of no or low interference from other molecules, the method can be used to detect glucose or methionine in various samples such as whole blood, plasma, serum, saliva, sweat, urine, washes of tissues, extracts of tissues, amniotic fluid, and placental fluid. Preferably, the method is used to detect glucose or methionine concentrations in whole blood, plasma, or serum samples. In one embodiment, where the method is used to measure an aqueous sample comprising serum, the serum is derived or taken from a human donor.
[0121] However, where the serum is derived from a human donor, excess protein may first need to be precipitated and removed from the sample before immersing the electrodes and measuring the current response. Here, the method may further comprise removing a precipitated protein from an aqueous sample that comprises serum. The protein may first be precipitated from a serum sample by chemical denaturation (for instance, mixing the serum with a base, detergent, and/or an organic solvent) or heating. In an alternative embodiment, the protein may be removed by chromatography, and without denaturation.
[0122] In one embodiment, the serum sample from a patient is mixed with an alcohol, including, but not limited to, methanol, ethanol, n-propanol, isopropanol, and n-butanol. Preferably the sample is mixed with methanol. The serum sample may be mixed with the alcohol at a volume ratio of 1:4-4:1, preferably 1:4-1:1, more preferably 1:3-1:2, or about 1:2. The serum sample and alcohol may be mixed for 5 min-3 hours, preferably 10 min-1 hour, or as long as overnight. This mixing may produce a precipitated protein.
[0123] The precipitated protein may then be removed by centrifugation and/or filtration. This may be performed by standard laboratory techniques. In one embodiment, the serum sample comprising precipitated protein may be centrifuged at 1,000-10,000 rpm, preferably 1,500-3,000 rpm, or about 2,000 rpm for 5-30 minutes, preferably 15-25 minutes, or about 20 minutes, to produce a clear supernatant. The clear supernatant may be filtered, for instance, with a 0.2-0.45 μm pore size filter.
[0124] The clear supernatant, or some other sample containing the analyte, may also be diluted before measurement. The clear supernatant or sample may be diluted 20-10,000 times, preferably 40-500 times, more preferably 50-300 times. It is preferred that a dilution factor is chosen so that an analyte concentration falls within or close to the linear response of the electrode measurement.
[0125] In one embodiment, some amount of analyte from a sample may be lost, especially if a sample is processed or filtered to remove protein or other compounds. However, the methods described herein may show a high amount of analyte recovery, preferably at least 96%, more preferably at least 97%, even more preferably at least 98%. Here, the analyte recovery is the percentage of the measured analyte concentration of the analyte with respect to the actual analyte concentration.
[0126] The reference electrode may be a standard hydrogen electrode, a normal hydrogen electrode, a reversible hydrogen electrode, a saturated calomel electrode, a silver chloride (Ag/AgCl) electrode, or a dynamic hydrogen electrode. Preferably, the reference electrode is a silver chloride (Ag/AgCl) electrode. In one embodiment, the reference electrode is an Ag/AgCl electrode, and the counter electrode comprises platinum, gold, or some other metal. Preferably the counter electrode is a platinum wire. The counter electrode may also be called an auxiliary electrode.
[0127] The graphite electrode is in electrical communication with the reference electrode. After the immersing, a potential is applied between the reference electrode and the modified graphite electrode to produce a current within the aqueous sample. The biasing potential may have the waveform of a linear scan voltammetry, a square wave voltammetry, or a cyclic voltammetry. In one embodiment, cyclic voltammetry may be applied, using a linear scan of voltage in both directions (low to high potential and high to low potential). In another embodiment, linear scan voltammetry may be used with a scan in only one direction. For instance, linear scan voltammetry may be used to scan from a high potential to a low potential, which is also called cathodic sweep linear scan voltammetry (CSLSV) is used. The potential applied in this region may cause surface oxidation reactions on the surface of the graphite electrode, which may be noticeable as current peaks. CSLSV may be used to scan from 1.5 V to −0.5 V, preferably 1.0 to −0.2 V. A voltage scan rate may be 10-400 mV/s, preferably 50-200 mV/s, more preferably 80-120 mV/s, or about 100 mV/s. However, in some embodiments, the voltage scan rate may be slower than 10 mV/s or faster than 400 mV/s. In an alternative embodiment, voltammetry may be used that does not scan linearly through a range of potentials, for instance, different potentials may be applied at discrete steps.
[0128] Changes in the current as a result of reduction or oxidation of analytes may be compared to a correlation chart or a calibration curve to determine the concentration of analyte. Here, the correlation chart or calibration curve relates an analyte concentration for a particular value of current measured. The correlation chart or calibration curve may be further influenced by other parameters such as voltage, temperature, pH, electrolyte concentration, and other solution conditions. Because of the influence of several solution conditions on the measurement of the analyte, the method may comprise a step of measuring standard solutions to construct a correlation chart or calibration curve. This provides a way to better ensure that certain solution conditions do not differ significantly between samples and standard solutions.
[0129] In one embodiment, cyclic voltammetry may be used with an aqueous sample to first identify the location of current peaks as a result of redox reactions. One or more current peaks may be observed in the cathodic sweep (high to low potential) and/or the anodic sweep (low to high potential). The value of the current peaks may be used from those cyclic voltammograms, or a linear scan voltammetry may next be applied using only a cathodic sweep or only an anodic sweep.
[0130] By changing the applied potential in any form of voltammetry, the current may vary based on electrochemical reaction of analyte. As mentioned previously, the current may peak during the voltage scan. For a particular analyte, this peak may occur at a particular voltage or within a smaller range of voltages, and the value of the current at the peak may be linearly dependent on the concentration of analyte. In one embodiment, the analyte is glucose, and the voltage of its current peak is 0.60-0.65 V, preferably 0.61-0.64 V, or about 0.63 V. In one embodiment, the analyte is methionine, and the voltage of its current peak is 0.63-0.67 V, preferably 0.64-0.66 V, or about 0.65 V. Preferably, these current peaks of glucose and methionine are observed in the cathodic region of the voltammogram (high potential to low potential), and these current peaks may be considered secondary oxidation peaks.
[0131] Alternatively, a linear response in current may be obtained by applying a potential at or near the voltage relating to the current peak of the particular analyte. In this sense, the measurement technique may be more similar to amperometry. The voltage may be constant or relatively stable, and the current or an average value of current is measured.
[0132] In one embodiment, the measuring further involves constructing a calibration curve from a current response of two or more standard solutions. This may be considered equivalent to constructing a calibration curve from a correlation chart. Preferably, the standard solutions comprise an identical analyte to the one being measured, though in other embodiments, the standard solutions may comprise a different species that has a similar electrochemical response. Preferably the standard solutions produce currents within the linear response range of the graphite electrode, so that a linear calibration curve may be determined to relate current to analyte concentration. Preferably, more than two standard solutions of different concentrations are used, for instance, 3-10 standard solutions, or 4-6 standard solutions. In one embodiment, separate standard solutions may each be prepared and measured one at a time. However, in another embodiment, standard solutions may be measured by a standard addition method, where one volume is measured, and then is mixed with standard solution (usually of a volume 10-1,000 times smaller), while the electrodes are kept in place.
[0133] Preferably, where standard solutions are used to construct a linear calibration curve, preferably the standard solutions are within a linear response range of the graphite electrode, so that the linear calibration curve has a correlation coefficient, R.sup.2, of at least 0.90, preferably at least 0.95, more preferably at least 0.97, even more preferably at least 0.99.
[0134] In one embodiment, where the analyte is glucose, the measurement method may have a limit of detection (LOD) of 0.03-5.0 μM, preferably 0.1-4.0 μM, more preferably 1.0-1.4 μM, or about 1.36 μM. The sensitivity of the electrode in this embodiment may be 20-1000 μA.Math.mM.sup.−1.Math.cm.sup.−2, preferably 100-800 μA.Math.mM.sup.−1.Math.cm.sup.−2, or about 315 μA.Math.mM.sup.−1.Math.cm.sup.−2.
[0135] In the embodiment where the analyte is methionine, the measurement method may have a limit of detection (LOD) of 0.01-5.0 μM, preferably 0.05-1.0 μM, more preferably 0.20-0.8 μM, or about 0.42 μM. The sensitivity of the electrode in this embodiment may be 100-10,000 μA.Math.mM.sup.−1.Math.cm.sup.−2, preferably 800-8,000 μA.Math.mM.sup.−1.Math.cm.sup.−2, or about 4,500 μA.Math.mM.sup.−1.Math.cm.sup.−2. The limit of quantification (LOQ) may be 0.5-70 μM, preferably 5-20 μM, or about 10 μM.
[0136] In one embodiment, rather than measuring a concentration of an analyte, linear scan voltammetry or cyclic voltammetry of the aqueous sample may be used to detect whether or not a sample is present. In this embodiment, the analyte concentration may be lower than, within, or greater than the linear response range of the graphite electrode. Additionally, this method of detection may rely on reporting the presence or absence of a peak in a voltammogram, rather than a particular value of current.
[0137] In one embodiment, the analyte concentration may be determined using amperometry and standard additions. Here, the potential may be held constant, and the level of current may be measured by sequentially adding and mixing standard additions, in order to increase the concentration by approximately the same amount each time. Each addition may be spaced by a time interval such as 20-100 s, or 30-60 s. A linear calibration curve may be similarly constructed as mentioned previously.
[0138] Following the measuring, the graphite electrode may be reusable and may be capable of repeated detection without calibration or replacement.
[0139] In one embodiment, the graphite electrode may be part of, or integrated in, a sensing device which comprises the aforementioned reference electrode and counter electrode. The sensing device may include a housing that comprises at least one graphite electrode, and a fluid distribution manifold that comprises a fluid flow path that is in fluid communication with the graphite electrode, the counter electrode, and the reference electrode. The fluid flow path may bring a fluid comprising at least one analyte in contact with the graphite electrode for sensing.
[0140] The sensing device may be in communication with at least one readout device that may generally be capable of measuring the current and/or potential at the graphite electrode. In most embodiments, the readout device may be a set of electronics. An electronic readout device, for example, may be capable of detecting current changes. Moreover, the readout device may be a component of the sensing device or may be separated from the sensing device. Furthermore, the readout device may also be linked to an adapter that may interface with a controller device. Preferably, a readout circuit used to enable determination of the presence and/or amount of analyte may form part of the readout device. In some embodiments, the readout circuit may be configured to measure the current and/or the potential at the graphite electrode. The readout circuit may also be configured to indicate the current and/or potential value(s) to a user of the sensing device such that he/she may detect the presence of the analyte and quantify it based on this measurement. To achieve this, the readout circuit may comprise an electronic display and/or a loudspeaker for presenting the current and/or potential value(s) to the user, and may further comprise a transmitter (or transceiver) for transmitting the data to another device. The latter feature enables the user to monitor the environment from a remote location. In another embodiment, the readout circuit may be configured to determine the presence and/or amount of analyte using the current and/or potential value(s) and indicate the result to the user (with or without the current and/or potential value(s)). This embodiment therefore provides the user with the end result without requiring him/her to derive it from the raw data.
[0141] In practice, this analysis would be performed by the processor in combination with a storage medium. For example, a processor may be configured to receive the current and/or potential value(s) from the readout circuit and compare this with predetermined calibration data (e.g. predetermined measurements of current and/or potential difference versus analyte concentration) from the storage medium to determine the presence and/or amount of analyte.
[0142] The examples below are intended to further illustrate protocols for preparing, and using graphite pencil electrodes for measurement and detection of glucose and methionine, and are not intended to limit the scope of the claims.
Example 1
Materials and Methods for Glucose Detection
Chemicals
[0143] A Cu AAS specification standard solution (1000 ppm±4.0) was prepared with nitric acid (HNO.sub.3) and sodium phosphate mono-basic anhydrous (NaH.sub.2PO.sub.4) obtained from Fluka. Sodium phosphate di-basic anhydrous (Na.sub.2HPO.sub.4), sodium hydroxide pellets, D-glucose, uric acid (UA), D-fructose, L-ascorbic acid (AA), and L-alanine were all used as purchased from Sigma-Aldrich. All solutions were prepared with double distilled water obtained from an AQUATRON water still A4000D water purification system.
Electroanalytical Apparatus and Procedures
[0144] The three electrode system comprises a pencil, made in Korea, which has a graphite lead that can be propelled or extruded mechanically as a working electrode, an Ag/AgCl saturated KCl electrode as a reference electrode, and platinum wire as a counter electrode. These three electrodes were connected with a CHI potentiostat workstation (CHI1140A, CH Instruments Inc, Austin, Tex., USA) for all electrochemical experiments and measurements, which additionally used a 0.10 M NaOH solution as supporting electrolyte. Descriptions, fabrication and working principle of the mechanical pencil have been reported in the literature. See J. Wang, A.-N. Kawde, Pencil-based renewable biosensor for label-free electrochemical detection of DNA hybridization, Analytica Chimica Acta, 431 (2001) 219-224, incorporated herein by reference in its entirety. About 7.00 mm length of graphite lead of 0.50 mm diameter propelled out of the vertically fixed pencil with an electrical contact achieved by soldering of copper on its metallic part were made to be in contact with the electrolyte solution corresponding to surface area of about 11.39 mm.sup.2.
[0145] Cyclic voltammetry (CV) measurements were done in the potential window of −0.20 V to 0.80 V with scan rate of 100 mV/s. Cathodic sweep linear scan voltammetry (CSLSV) techniques were employed as the electrochemical technique for glucose determination between 1.00 V and −0.20 V potential. Measurements were taken at room temperature, and the accumulations step was done under stirring before cathodic sweeping at quiescent condition after 5 s of quiet time.
GPE Surface Characterization
[0146] Images of GPE were recorded with FE-SEM and EDX instruments by TESCAN LYRA 3 at the Center of Research Excellence in Nanotechnology, King Fand University of Petroleum and Minerals (KFUPM), Kingdom of Saudi Arabia (KSA). X-ray photon Spectroscopy (XPS) investigation was performed with Thermo-Scientific ESCALAB-250Xi instrument with monochromatic Al Kα radiation, hv=1486.6 eV, installed in the Physics Department of KFUPM, KSA. Data obtained from XPS was processed with THERMO AVANTAGE, version 5.51, Surface Chemical Analysis software.
Serum Sample Collection and Preparation
[0147] A serum sample was collected from a healthy patient with the assistance of the Imam Abdulrahman Teaching Hospital blood bank section (King Fand Teaching Hospital). The serum sample was stored in the refrigerator to defrost, and a 450 μL aliquot was taken and treated with methanol (900 μL) in a 1:2 volume ratio to precipitate protein from the serum sample. The precipitated protein was from the sample with 20 minutes of centrifugation at 2000 rpm and filtering the clear supernatant with a of 0.45 μm pore size MILLIPORE filter.
Example 2
Results and Discussion for Glucose Detection
Redox Reactions of Glucose in the Presence of Copper on GPE
[0148] In the absence of Cu, as shown in curves “b” and “c” of
[0149] The electrochemical redox reaction of Cu(NO.sub.3).sub.2 on the surface of GPE was studied by multiple cycles of CV to probe the reduction peak of Cu.sup.2+ to Cu.sup.+ in 0.1 M NaOH solution.
FE-SEM and EDX Analysis
[0150] The effects of the Cu.sup.2+ to Cu.sup.+ reduction peak on the surface of GPE were investigated by FE-SEM/EDX analysis after 25 cycles CV as measured previously in
[0151] The chemical state of the Cu revealed by the EDX elemental analysis (
Proposed Glucose Redox Reactions Mechanism on GPE
[0152] Oxidations of different forms of copper immobilized on solid electrodes to +1, +2 and +3 oxidation states for glucose detection have been reported with mechanisms supporting copper peroxide (CuOOH) which have often referred to as Cu.sup.3+ as the species responsible for electrocatalysis of glucose in basic medium. These mechanisms are shown in eqn. (1-3). See A. A. Ensafi et al.; C. Kong et al.; S. Pourbeyram et al.; J. Xu et al.; and B. Wang et al., each incorporated herein by reference in their entirety. This mechanism is valid for oxidation of glucose based on the abstraction of hydrogen from the β-OH group of the hemiacetal carbon center (carbon with ether and alcohol groups) by Cu.sup.3+ species and can be supported by a comprehensive study of Cu.sup.3+ complex for hydrogen atom abstraction from hydrocarbon. See D. Dhar, W. B. Tolman, Hydrogen Atom Abstraction from Hydrocarbons by a Copper(III)-Hydroxide Complex, Journal of the American Chemical Society, 137 (2015) 1322-1329, incorporated herein by reference in its entirety. However, Cu.sup.2+ species complex have also been reported to be an active hydrogen atom abstraction from organic molecules. See M. Taki, H. Kumei, S. Itoh, S. Fukuzumi, Hydrogen atom abstraction by Cu(II)- and Zn(II)-phenoxyl radical complexes, models for the active form of galactose oxidase, Journal of Inorganic Biochemistry, 78 (2000) 1-5, incorporated herein by reference in its entirety.
Cu.sup.0+20H.sup.−.fwdarw.CuO+H.sub.2O+2e.sup.− or Cu.sup.0+20H.sup.−.fwdarw.Cu(OH).sub.2+H.sub.2O+2e.sup.− (1)
CuO+OH.sup.−.fwdarw.CuOOH+e.sup.− or CuO+H.sub.2O+20H.sup.−.fwdarw.Cu(OH).sub.4.sup.−+e.sup.− (2)
Cu.sup.3++glucose+e.sup.−.fwdarw.gluconolantone+Cu.sup.2+ (3)
[0153] It is worth mentioning that none of the equations (1-3) represents a redox reaction of Cu (either metallic or Cu.sup.2+) to +1 oxidation state. Besides, a misrepresentation of oxidation state of Cu in CuOOH as shown in equation (2) needs special consideration. The oxidation state of Cu in CuOOH is +1, in contrast to +3, because oxygen always has an oxidation number of −1 in peroxides. So, equation (2) can also be possible electrochemically by reduction reaction of Cu.sup.2+ to Cu.sup.+ by gaining of an electron as shown in
[0154] The scheme in
Cu(OH).sub.2+OH.sup.−+e.sup.−.fwdarw.CuOOH+H.sub.2O (Reduction) (4)
CuOOH (Cu.sup.+)+glucose.fwdarw.gluconolactone+Cu(OH).sub.2+e.sup.− (Oxidation) (5)
Gluconolactone+H.sub.2O.fwdarw.Gluconic acid (Hydrolysis) (6)
Effect of Cu Concentration on Glucose Oxidation
[0155] CSLSV was used for subsequent electrochemical investigations since all the reactions involving glucose detection occur on the cathodic segment of the CVs as presented in
Electro-Catalytic Activity of Cu in Glucose Oxidation
[0156] Effects of Cu as an effective electro-catalyst of glucose on the surface of GPE at optimized parameters (−0.20 V accumulation potential, 60 s accumulation time, 6 mV sample interval, and 75 mV/s scan rate) for 1 mM glucose in the presence of 2.00 ppm Cu were adequately demonstrated in
Electro-Analytical Performance
[0157] CSLSVs of oxidation of glucose on GPE in a medium comprising 0.10 M NaOH and 2.00 ppm Cu conditions are presented in
[0158] The corresponding calibration curve for the GPE response to glucose is shown in
TABLE-US-00001 TABLE 1 Electroanalytical performance of different forms of copper modified electrodes for glucose detection Linear Electrode LOD range Sensitivity Materials Techniques (μM) (mM) (μA .Math. mM.sup.−1 .Math. cm.sup.−2) Medium Ref..sup.† Bare GPE CSLSV 1.36 0.06-4.sup. 315 0.1M Present NaOH with work Cu std solution CuNcs- Amperometry 1 Up to 7.5 1096 0.1M (a) MWCNTs\GC NaOH CuO-Np-CC Amperometry 1 Up to 1.22 1245.9 0.1M (b) CuO-Nw-CC 1 Up to 1.12 2973.2 NaOH CuO-Ns-CC 1 Up to 1 4901.9 CuNps- Amperometry 0.5 0.01-0.3 714 0.02M (c) MWCNTs\GC NaOH CuNps- RGO\GC Amperometry 0.2 0.005-1.4 604 0.1M (d) NaOH CuNps-GS\GC Amperometry 0.5 Up to 4.5 0.1M (e) NaOH CuNws\GC Amperometry 1 Up to 3 420 0.05M (f) NaOH Cu-Psi\CP Amperometry 0.2 0.001-0.19, — 0.1M (g) 0.19-2.3 NaOH CuO polyhedron- Amperometry 0.33 Up to 4 1112 0.1M (h) Nafion\GC NaOH CuNps\GP DPV 0.44 1-6 1467 0.1M (i) NaOH Cu—PMo.sub.12-GR\GC Amperometry 0.03 0.001-1 — 0.1M (j) NaOH Cu-RGO\FP Amperometry 0.002-2 50.4.sup.(a) 0.1M (k) 2-13 NaOH
Abbreviations: CSLSV: cathodic sweep linear scan voltammetry; DPV: differential pulse voltammetry; GP: graphite pencil; CC: carbon clothes; GC: glassy carbon; FP: flexible paper; GS: graphene sheet; RGO: reduced graphene oxide; Psi; Porous silicon; PMo.sub.12: Phosphomolybdic acid; Ns: nano sheet; Nw: nanowire; Np: nano particle; a: mA.Math.mM.sup.−1 cm.sup.−2
† Table 1 References: (a) J. Yang, W.-D. Zhang, S. Gunasekaran, An amperometric non-enzymatic glucose sensor by electrodepositing copper nanocubes onto vertically well-aligned multi-walled carbon nanotube arrays, Biosensors and Bioelectronics, 26 (2010) 279-284; (b) Y. Zhong, et al.; (c) H.-X. Wu, W.-M. Cao, Y. Li, G. Liu, Y. Wen, H.-F. Yang, S.-P. Yang, In situ growth of copper nanoparticles on multiwalled carbon nanotubes and their application as non-enzymatic glucose sensor materials, Electrochimica Acta, 55 (2010) 3734-3740; (d) J. Luo, H. Zhang, S. Jiang, J. Jiang, X. Liu, Facile one-step electrochemical fabrication of a non-enzymatic glucose-selective glassy carbon electrode modified with copper nanoparticles and graphene, Microchimica Acta, 177 (2012) 485-490; (e) J. Luo, et al.; (f) Y. Zhang, L. Su, D. Manuzzi, H. V. E. de los Monteros, W. Jia, D. Huo, C. Hou, Y. Lei, Ultrasensitive and selective non-enzymatic glucose detection using copper nanowires, Biosensors and Bioelectronics, 31 (2012) 426-432; (g) A. A. Ensafi, et al.; (h) C. Kong, et al.; (i) S. Pourbeyram, et al.; (j) J. Xu, et al.; (k) B. Wang, et al., each incorporated herein by reference in their entirety.
Potential Interference from Other Compounds on Glucose Detection
[0159] The co-existence of some saccharides (such as fructose), amino acids (such as alanine) and ascorbic acid (AA), along with glucose in real life samples necessitate the investigation to prove the potency of the sensor in the presence of these potential interferences. Concentrations of AA and some other interferences are always below 0.10 mM compared to the physiological level of glucose which has been estimated to be between 3.00 to 8.00 mM. See Z. Zhuang, X. Su, H. Yuan, Q. Sun, D. Xiao, M. M. F. Choi, An improved sensitivity non-enzymatic glucose sensor based on a CuO nanowire modified Cu electrode, Analyst, 133 (2008) 126-132, incorporated herein by reference in its entirety. Base the physiological ratio of glucose to its potential interferences, 0.10 mM of AA (
Voltammetric Determination of Glucose in Serum Sample
[0160] Developed technique was tested on the serum sample obtained from a healthy patient in King Fand University Teaching Hospital. Protein-free serum sample diluted 200 times in 0.10 M NaOH was used for analysis of glucose by spiking of a series of glucose standard solutions. Results of the serum sample analysis are enumerated in Table 2. About 0.04 mM glucose concentration equivalent to about 8.00 mM glucose concentration in the undiluted serum was found with a good recovery range between 97-110%. This performance is an indication of the capability of the developed technique with bare GPE in the presence of Cu for a real life application.
[0161] A unique and cost effective voltammetric technique for the development of a non-enzymatic glucose sensor by in-situ reduction of Cu.sup.2+ to Cu.sup.+ and electrochemical oxidation of glucose on the surface of graphite pencil electrode (GPE) was proposed. Adsorbed Cu.sup.+ on GPE was characterized with flame emission scanning electron microscope-electron dispersed X-ray (FESEM-Edx) and X-ray spectroscopy (XPS). Electro-catalytic property of copper (Cu) was explored to enhance the secondary oxidation current-peak of glucose at about 0.63 V to more than 10 fold (>1,000%) in 0.1 M NaOH solution. Linearity dependence of the electrode was determined as i(μA)=3.5985C.sub.glu+0.0143 for 0.06-4.0 mM concentration of glucose with a correlation coefficient (R.sup.2) of 0.9927, sensitivity of 315 μA.Math.mM.sup.−1.Math.cm.sup.−2, and limit of detection (S/N=3) of 1.36 μM. Developed technique is an inexpensive and competent method for the development of a non-enzymatic glucose sensor for human fluid samples due to almost no interference of L-ascorbic acid (AA), alanine, and fructose with the current-peak of glucose.
TABLE-US-00002 TABLE 2 Glucose detection in healthy human serum sample Amount Spiked Amount Amount Found Recovered % # (mM) (mM) (mM) Recovery 1 0.50 0.04 0.49 97.00 2 1.00 0.04 1.01 101.30 3 1.50 0.04 1.52 101.56 4 2.00 0.04 1.98 98.98
Example 3
Materials and Methods for Methionine Detection
Chemicals
[0162] 1000 mg/L±4.00 Ag standard was prepared in nitric acid having a AAS specification from Fluka. NaOH pellets, DL-methionine, L-ascorbic acid, L-alanine, and L-cysteine were supplied by Sigma-Aldrich. For the supporting electrolyte, phosphate buffer solution, pH 7.00, 0.10 M, was prepared by mixing appropriate volumes of 0.20 M monosodium phosphate and disodium phosphate prepared with double distilled water and sodium acetate. These salts were all used as collected from Sigma-Aldrich. All solutions were prepared with double distilled water obtained from AQUATRON water still A4000D water purification system.
Electrochemical Cell and Procedure A system comprising 3 electrodes was utilized with 0.10 M NaOH and phosphate buffer solution (PBS) as supporting electrolyte. PBS was prepared with appropriate mixture of sodium phosphate mono and di-basic anhydrous salts. The working electrode is a graphite pencil lead whose fabrication, description, and working principle have been widely reported previously. See J. Wang, A.-N. Kawde, Pencil-based renewable biosensor for label-free electrochemical detection of DNA hybridization, Anal. Chim. Acta 431 (2001) 219-224, incorporated herein by reference in its entirety. Platinum wire and Ag/AgCl saturated KCl were connected with CHI potentiostat workstation (CHI1140A, CH Instruments Inc, Austin, Tex., USA) as counter and reference electrodes, respectively, for all electroanalytical measurements. Approximately 10 mm length of 0.50 mm diameter graphite lead corresponding to about 16.10 mm.sup.2 surface area was propelled out of a vertically positioned pencil through a TEFLON hole to make contact with the supporting electrolyte. Electrical contact of the graphite lead was achieved by soldering copper wire with the metallic part of the pencil.
[0163] Electroanalytical techniques adapted for the electrochemical studies are cyclic voltammetry and linear scan voltammetry (CSLSV) for the analytical performance of the developed technique at room temperature and cathodic sweeping at quiescent condition.
Surface Characterization of GPE
[0164] Images of GPE were recorded by FE-SEM by a TESCAN LYRA 3 instrument from the Center of Research Excellence in Nanotechnology (CENT), King Fand University of Petroleum and Minerals (KFUPM), Kingdom of Saudi Arabia (KSA). X-ray photon Spectroscopy (XPS) investigation was performed with Thermo-Scientific ESCALAB-250Xi instrument with monochromatic Al Kα radiation (hv=1486.6 eV) installed in the Physics Department of KFUPM, KSA. Data obtained from XPS were processed with Thermo Advantage version 5.51, Surface Chemical Analysis software.
Real Sample (Serum) Preparation
[0165] The collection of the serum sample from a healthy patient was achieved with the assistance of Imam Abdulrahman University Teaching Hospital's blood bank section (King Fand University, Hospital). The serum sample was stored in the refrigerator to defrost, and a 450 μL aliquot was taken and treated with methanol (900 μL) in a 1:2 volume ratio to separate the protein from the serum sample. The precipitated protein was separated by centrifuging the mixture for 20 minutes at 2000 rpm, decanting, and subsequently filtering the clear supernatant with a Millipore filter having a 0.45 μm pore size.
Example 4
Results and Discussion for Methionine Detection
Effect of Buffer on Methionine Redox Reactions on GPE
[0166] Cyclic voltammograms (CVs) showing the redox reaction of methionine in 0.1 M PBS pH 7.00±0.20, and 0.10 M NaOH pH 13.70±0.20, are shown in
[0167] Electrochemical redox reaction of AgNO.sub.3 on the surface of GPE was further studied in PBS and NaOH electrolyte by multiple cycle CV.
Characterization of GPE Surface—FE-SEM and EDX Analysis
[0168] Effects of the oxides layers on the surface of GPE (
Characterization of GPE Surface XPS Analysis
[0169] Investigation of the oxidation states of Ag presence on GPE surface 5 ppm AgNO.sub.3 in 0.10 M PBS and NaOH by XPS Ag 3d and O 1s spectra are presented in
Effect of Ag Concentration on Methionine Oxidation
[0170] Based on the redox peaks of Ag on the GPE surface and the oxidation of methionine in the cathodic region of the CVs shown in
Electro-Analytical Performance
[0171] Performance of the developed sensor was ascertained by constructing a calibration curve (
[0172] A calibration curve for the corresponding voltammograms of methionine is shown in
TABLE-US-00003 TABLE 3 Performance Comparison of Different Modified Electrode with GPE in the Presence of AgNO.sub.3 for Methionine Determination. Linear LOD Range Transducer Medium Technique (μM) (μM) Ref..sup.†† Ru-Metden/ 0.1M PBS, Amper- 0.60 1-10 (a) CtCE pH 7.0 ometry CAu-Cystm/ 0.1M PBS, DPV 0.56 1-100 (b) CPE pH 7.0 Ni—P/CCE 0.1M NaOH Ch-Amp 2 2-90 (c) Fullerene-C.sub.60/ 0.1M KNO.sub.3 HDV 8.2 Up (d) AuE to 100 SPGME 0.1M PBS, DPV 95 50-5000 (e) pH 7.0 p-4α- 0.2M PBS, DPV 0.027 50-500 (f) Cu.sup.IITAPc/ pH 4.0 GCE TiO.sub.2—Pt/CNT/ 0.1M PBS, Amper- 0.1 0.5-100 (g) GCE pH 7.0 ometry MWCNT- 0.1M PBS DPCSV 0.02 0.08-10 (h) NFMIP/ pH 2.0 DGLPE RGO-GCE 0.1M PBS, DPV 100 450-4950 (i) pH 5.5 Ag—Au 0.1M PBS, LSV & 30 50-500 (j) (BMNp)/GCE pH 7.0 ch-Amp Bare DGLPE 0.1M NaOH, CLSV& 0.42 10-500 This AgNO.sub.3 Amp work
Abbreviations: Ru: Ruthenium (II); Metden: Metallodendrimer; CAu: Colloidal Gold; Cystm: Cysteamine; Ni—P/CCE: Nickel Powder Doped Carbon Ceramic Electrode; SPGME: Screen Printed Graphite Macroelectrode; p-4α-Cu.sup.IITAPc: 1,8,15,22-tetraaminophthalocyanato-copper(II); NFMIP: Nano film molecular Imprinted; BMNp: Bimetallic Nanoparticle; CNT: Carbon Nanotube; MWCNT: Multiple wall Carbon Nanotube; RGO: reduced graphene; CtCE: Conducting Composite Electrode; DGLPE: Renewable Graphite Lead Pencil Electrode; GCE: glassy Carbon Electrode; CLSV: Cathodic Linear Scan Voltammetry; DPV: Differential Pulse voltammetry; Ch-Amp: Chronoamperometry.
†† Table 3 References: (a) S. D. Holmstrom, J. A. Cox, Electrocatalysis at a conducting composite electrode doped with a ruthenium(II) metallodendrimer, Anal. Chem. 72 (2000) 3191-3195; (b) L. Agüi, J. Manso, P. Yáñez-Sedeño, J. M. Pingarrón, Colloidal-gold cysteamine-modified carbon paste electrodes as suitable electrode materials for the electrochemical determination of sulphur-containing compounds: Application to the determination of methionine, Talanta 64 (2004) 1041-1047; (c) A. Salimi, et al.; (d) W. T. Tan, J. K. Goh, Electrochemical oxidation of methionine mediated by a fullerene-C 60 modified gold electrode, Electroanal. 20 (2008) 2447-2453; (e) M. Gomez-Mingot, J. Iniesta, V. Montiel, R. O. Kadara, C. E. Banks, Direct oxidation of methionine at screen printed graphite macroelectrodes: Towards rapid sensing platforms, Sens. Actuators, B 155 (2011) 831-836; (f) A. J. Jeevagan, et al.; (g) F. Chekin, et al.; (h) B. B. Prasad, et al.; (i) D. Zhang, et al.; (j) M. Murugavelu, et al., each incorporated herein by reference in their entirety.
Amperometric Response and Interference Studies
[0173] Amperometric response of the developed sensor to successive additions of 20 μM methionine at 0.65 V at different time interval is shown in
[0174] Interference studies of methionine with ascorbic acid (AA), L-alanine (Aln) and cysteine (Cyt), which are representative of essential vitamins and amino acids that can co-exist with methionine in human serum, were investigated with the amperometric measurement technique at the same 0.65 V (
Application of the Developed Technique on Serum Sample
[0175] Methionine concentration was analyzed by a standard addition method using a serum sample obtained from a healthy patient at the King Fand University Teaching Hospital. The sample was treated to remove protein, and 50 ρ.L was spiked in the 0.1 M NaOH to make a 100 times dilution of the serum. A good response of the serum on GPE can be observed in (b) of
[0176] A proficient and cost effective electrochemical method by in-situ single-step AgO modification of a graphite pencil electrode (GPE) and determination of serum methionine have been successfully developed and characterized. Electro-catalytic activity of Ag in 0.10 M NaOH pH 13.70±0.20 in the presence of AgNO.sub.3 was used to initiate the oxidation reaction of methionine on GPE surface by a Ag.sup.2+ metal-induced reaction by hydroxyl radical (OH.) readily available mechanism. Other supporting electrolytes explored (0.10 M PBS pH 7.00±0.20) could not initiate oxidation of methionine. Electrode linearity dependence obtained is given as i(μA)=73.314C.sub.DLM+1.1459 for a linear range concentration of 10-500 μM with correlation coefficient (R.sup.2) of 0.9927 and limit of detection of 0.42 μM. Effects of potential interferences such as ascorbic acid (AA), L-alanine (Aln) and cysteine was found to be insignificant. Developed method was found to be suitable for both voltammetric and amperometric techniques for the development of non-enzymatic sensor for methionine and its real life application on human serum sample by standard addition method with correlation coefficient (R.sup.2) of 0.999. The developed method is also suitable in the presence of potential interferences such as ascorbic acid, L-alanine, and cysteine.
TABLE-US-00004 TABLE 2 Methionine Detection in Healthy Human Serum Sample Amount Spiked Amount Recovered Amount Found % # (mM) (mM) (μM) Recovery 1 0.05 0.055 9.69 109.88 2 0.10 0.099 9.69 99.32 3 0.15 0.149 9.69 99.38 4 0.20 0.197 9.69 98.34 5 0.25 0.252 9.69 100.99